The spectrum of factor XI deficiency in Italy

Factor XI (FXI) deficiency is a rare inherited bleeding disorder invariably caused by mutations in the FXI gene. The disorder is rather frequent in Ashkenazi Jews, in whom around 98% of the abnormal alleles is represented by Glu117X and Phe283Leu mutations. A wide heterogeneity of causative mutations has been previously reported in a few FXI deficient patients from Italy. In this article, we enlarge the knowledge on the genetic background of FXI deficiency in Italy. Over 4 years, 22 index cases, eight with severe deficiency and 14 with partial deficiency, have been evaluated. A total of 21 different mutations in 30 disease‐associated alleles were identified, 10 of which were novel. Among them, a novel Asp556Gly dysfunctional mutation was also identified. Glu117X was also detected, as previously reported from other patients in Italy, while again Phe283Leu was not identified. A total of 34 heterozygous relatives were also identified. Bleeding tendency was present in very few cases, being inconsistently related to the severity of FXI deficiency in plasma. In conclusion, at variance with other populations, no single major founder effect is present in Italian patients with FXI deficiency.

[1]  C. Rosano,et al.  Genetic analysis in FXI deficient patients from northwestern Italy: three novel and one recurrent mutation , 2013, European journal of haematology.

[2]  S. Moro,et al.  A cluster of factor XI‐deficient patients due to a new mutation (Ile 436 Lys) in northeastern Italy * , 2012, European journal of haematology.

[3]  E. Di Cera,et al.  Crystal structures of prethrombin-2 reveal alternative conformations under identical solution conditions and the mechanism of zymogen activation. , 2011, Biochemistry.

[4]  François Stricher,et al.  A graphical interface for the FoldX forcefield , 2011, Bioinform..

[5]  G. Tiscia,et al.  Factor XI deficiency: two novel mutations in asymptomatic Italian patients , 2010, Haemophilia : the official journal of the World Federation of Hemophilia.

[6]  P. McEwan,et al.  Structure and function of factor XI. , 2010, Blood.

[7]  V. Rimoldi,et al.  Analysis of the structural effects of four novel and a previously known mutations causing factor XI deficiency , 2009, Thrombosis and Haemostasis.

[8]  M. Landau,et al.  Three residues at the interface of factor XI (FXI) monomers augment covalent dimerization of FXI , 2009, Journal of thrombosis and haemostasis : JTH.

[9]  S. Duga,et al.  Factor XI gene mutations in factor XI deficient patients of the Czech Republic , 2008, American journal of hematology.

[10]  S. P. Bajaj,et al.  An Analysis of Cleavage of the Factor IX Activation Sites by Factor XIa , 2008 .

[11]  S. Duga,et al.  Severe factor XI deficiency in the Abruzzo region of Italy is associated to different FXI gene mutations , 2008, Haematologica.

[12]  P. Mannucci,et al.  Simultaneous genotyping of coagulation factor XI type II and type III mutations by multiplex real-time polymerase chain reaction to determine their prevalence in healthy and factor XI-deficient Italians , 2008, Haematologica.

[13]  P. de Mazancourt,et al.  Four novel FXI gene mutations in three factor XI- deficient patients , 2008, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

[14]  I. Guella,et al.  Molecular characterization of two novel mutations causing factor XI deficiency: A splicing defect and a missense mutation responsible for a CRM+ defect , 2008, Thrombosis and Haemostasis.

[15]  G. R. Lari,et al.  Seven novel point mutations in the F11 gene in Iranian FXI‐deficient patients , 2007, Haemophilia : the official journal of the World Federation of Hemophilia.

[16]  Joost Schymkowitz,et al.  The stability effects of protein mutations appear to be universally distributed. , 2007, Journal of molecular biology.

[17]  U. Seligsohn,et al.  Factor XI in haemostasis and thrombosis: Past, present and future , 2007, Thrombosis and Haemostasis.

[18]  J. Peynet,et al.  Identification of five novel mutations in the factor XI gene (F11) of patients with factor XI deficiency , 2006, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

[19]  R. Babine,et al.  Mutation of surface residues to promote crystallization of activated factor XI as a complex with benzamidine: an essential step for the iterative structure-based design of factor XI inhibitors. , 2005, Acta crystallographica. Section D, Biological crystallography.

[20]  D. Perry,et al.  Factor XI deficiency database: an interactive web database of mutations, phenotypes, and structural analysis tools , 2005, Human mutation.

[21]  T. Dang,et al.  Dominant factor XI deficiency caused by mutations in the factor XI catalytic domain. , 2004, Blood.

[22]  R. Mountford,et al.  A common ancestral mutation (C128X) occurring in 11 non‐Jewish families from the UK with factor XI deficiency , 2004, Journal of thrombosis and haemostasis : JTH.

[23]  M. Trossaërt,et al.  Molecular basis of severe factor XI deficiency in seven families from the west of France. Seven novel mutations, including an ancient Q88X mutation , 2004, Journal of thrombosis and haemostasis : JTH.

[24]  David S. Wishart,et al.  VADAR: a web server for quantitative evaluation of protein structure quality , 2003, Nucleic Acids Res..

[25]  L. Serrano,et al.  Predicting changes in the stability of proteins and protein complexes: a study of more than 1000 mutations. , 2002, Journal of molecular biology.

[26]  F. Bauduer,et al.  Factor XI deficiency in French Basques is caused predominantly by an ancestral Cys38Arg mutation in the factor XI gene. , 2002, Blood.

[27]  M. Mitchell,et al.  Identification of a novel mutation in a non‐Jewish factor XI deficient kindred , 1999, British journal of haematology.

[28]  M. Mittelman,et al.  The two common mutations causing factor XI deficiency in Jews stem from distinct founders: one of ancient Middle Eastern origin and another of more recent European origin. , 1997, Blood.

[29]  J. Hancock,et al.  Six point mutations that cause factor XI deficiency. , 1995, Blood.

[30]  A. Chetrit,et al.  One of the two common mutations causing factor XI deficiency in Ashkenazi Jews (type II) is also prevalent in Iraqi Jews, who represent the ancient gene pool of Jews. , 1995, Blood.

[31]  A. McCraw,et al.  Inheritance and bleeding in factor XI deficiency , 1988, British journal of haematology.

[32]  E. Davie,et al.  Organization of the gene for human factor XI. , 1987, Biochemistry.

[33]  E. Mammen,et al.  Factor XI Deficiency , 1983, Definitions.

[34]  E. Santagostino,et al.  Molecular genetic analysis of severe coagulation factor XI deficiency in six Italian patients. , 2004, Haematologica.

[35]  W. Delano.  The PyMOL Molecular Graphics System , 2002 .